Dr. Cianfrocca is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1500 Duarte Rd
Duarte, CA 91010Phone+1 626-256-4673Fax+1 626-408-3911
Education & Training
- Arizona State University WP Carey School of BusinessMBA, 2016
- McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 1996 - 1999
- Rush University Medical CenterResidency, Internal Medicine, 1990 - 1994
- Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 1989
Certifications & Licensure
- CA State License 2020 - 2025
- AZ State License 2011 - 2022
- IL State License 1989 - 2011
- PA State License 1999 - 2004
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- BMS-214662 Plus Trastuzumab in Treating Patients With Advanced Solid Tumors Start of enrollment: 2001 Jul 01
- Sulindac and Docetaxel in Treating Women With Metastatic or Recurrent Breast Cancer Start of enrollment: 2002 Jan 01
- Cyclosporine A in Combination With Nab-Paclitaxel in Patients With Metastatic Breast Cancer Start of enrollment: 2010 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 117 citationsRandomized trial of paclitaxel versus pegylated liposomal doxorubicin for advanced human immunodeficiency virus-associated Kaposi sarcoma: evidence of symptom palliati...Mary Cianfrocca, Sandra J. Lee, Jamie H. Von Roenn, Anile Tulpule, Bruce J. Dezube
Cancer. 2010-08-15 - 19 citationsPilot study evaluating the interaction between paclitaxel and protease inhibitors in patients with human immunodeficiency virus-associated Kaposi’s sarcoma: an Eastern...Mary Cianfrocca, Sandra J. Lee, Jamie H. Von Roenn, Michelle A. Rudek, Bruce J. Dezube
Cancer Chemotherapy and Pharmacology. 2011-01-05 - 116 citationsAnastrozole versus tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy plus radiotherapy (NSABP B-35): a randomised, double-blind, ph...Richard G. Margolese, Reena S. Cecchini, Thomas B. Julian, Patricia A. Ganz, Joseph P. Costantino
Lancet. 2016-02-27
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: